about
Interferon for anogenital warts in non-immunocompromised adultsTreatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation.Antiviral drugs for viruses other than human immunodeficiency virusPreventing cervical cancer by treating genital warts in men. Why male sex partners need androscopy.External genital warts: diagnosis, treatment, and prevention.Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier.Interferon for the treatment of genital warts: a systematic review.Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled studyImiquimod, a patient-applied immune-response modifier for treatment of external genital warts.Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study.Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferonPathogenesis of genital HPV infection.A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminataCombined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital wartsRandomised double-blind trial of recombinant interferon-beta for condyloma acuminatumIntralesional interferon alfa-2b treatment of condylomata acuminata previously resistant to podophyllum resin application.Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.Laser treatment of recurrent urethral condylomata acuminata in men.Human papillomavirus infections: epidemiology, pathogenesis, and therapy.Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health ExaminationThe interferons and their use in condyloma acuminata.Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model.HIV-related infections of the oral cavity.Antiviral therapy: current concepts and practicesGenital warts. Newly discovered consequences of an ancient disease.Surgical Management of Giant Genital Condyloma Acuminata by Using Double Keystone FlapsDisease-activated transcription factor: allergic reactions in human skin cause nuclear translocation of STAT-91 and induce synthesis of keratin K17.Human papillomavirus, condylomata acuminata, and anal neoplasia.Practical techniques to enhance the safety of health care workers in office-based surgery.Interferon for treatment: the dust settles.Lasers in gynecology: why pragmatic surgeons have not abandoned this valuable technology.Headache associated with non-cephalic infections: classification and mechanisms.New therapies for genital warts.Intralesional interferon alpha-2b in treating refractory meatal and anal warts.The effect of topical interferon alpha 2b on actinic keratoses.Interferon: current and future clinical uses in infectious disease practice.Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study.Anogenital warts in prepubertal children; sexual abuse or not?Efficacy and safety of combined high-dose interferon and red light therapy for the treatment of human papillomavirus and associated vaginitis and cervicitis: A prospective and randomized clinical study
P2860
Q24240816-6631CF00-F16C-46C2-924D-4A041690ADEEQ24530199-31D4B43E-5775-4815-9BE6-4540031C8056Q24635330-2FB9C8A5-E843-4712-BDC4-D1EC0603B61BQ30824729-3C10E42A-E35F-4EBB-B2B1-CF05CFE27D99Q31112715-ECC99488-C837-4ACC-8304-E156F7806AA1Q31901669-F8494D49-F1C6-479C-A1E0-06386E551972Q33505782-5C830923-530E-4A0E-A39B-0D2FA1FA7253Q33544689-69FC703D-AD79-4BB6-9D3D-D86D1B3D4C41Q33692334-C69C20F4-C39E-4699-9A01-592F13A789DEQ33933193-773E9840-60DE-4901-8F8E-350BF365B0B1Q33934275-59A55156-99BB-47D0-8C7A-C8130A9AFDB8Q33934353-9C5A5E91-5727-40E6-8A6C-F0DC989FBF4EQ33935074-C7368E3D-7F8D-4C25-BDE1-09B1387F0709Q33936023-506818E8-2865-4BDA-A3BE-7536AD36625CQ33936037-6D24E968-95F3-419F-A8D6-D5B6E000DD7EQ33937927-9D9E8BA4-C4AF-4C8B-8056-5B029E338C31Q34106393-6E0469BD-EA0B-44D3-A8CC-0F42EB68FBF4Q34175031-01EF621C-E23C-4262-B55B-395F96A13CA9Q34204141-120FEFAF-32BF-4099-B071-FF04FF415C9DQ34278627-AE8928A4-9ED5-4A28-A077-712ABFACC2D3Q35323052-33608E3A-E14C-4CE1-85DD-1591A05F6B3FQ35341809-2EE643E8-832F-4E31-9F06-ADC91730C0CCQ36043918-1AA2AFDD-D881-43CC-86A9-C42016163DFFQ36070394-E7F48487-3340-4ABF-B497-35F3FB152B36Q36158300-D45928D9-4719-4D8D-88D3-0314F23C2A26Q36224246-969CE6B5-07D1-48E9-97A7-4454EFE5C040Q36657271-F1FF6AA9-B803-41F0-9686-F13CDC7CB2FBQ37427460-B840F972-D328-421B-9EEF-E5976196F566Q37835370-E4AB9075-7309-4018-A80D-30FB20C84F65Q38190337-7E1020E1-E9F3-4394-A102-9BEB5A7FB552Q39230594-7A5C95C3-7EAE-40A1-960C-4813BB46B9F7Q40730606-54DEB259-9FA9-4762-932D-90E09D2E467DQ41168850-F5ED7B27-40C2-44F7-8CEB-7FF537AA443AQ42946093-72D72B3A-4CB9-43FB-A714-31270834507CQ44577524-0919152E-2586-41C9-B52C-F94FE60FB06FQ44717382-0E04F7E9-23C5-4B16-8056-5D208C9D17A8Q45113297-69407479-E0F5-477F-A7CC-4437EB7D4251Q51657589-195E949B-BFFD-4254-B349-E7F721E9B25AQ58739663-EC6321B7-42A2-4803-955D-8287B6812A97
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Interferon therapy for condylomata acuminata.
@en
type
label
Interferon therapy for condylomata acuminata.
@en
prefLabel
Interferon therapy for condylomata acuminata.
@en
P2093
P1476
Interferon therapy for condylomata acuminata.
@en
P2093
Flannigan S
P304
P356
10.1056/NEJM198610233151704
P407
P577
1986-10-01T00:00:00Z